Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

BIT 225

Next Previous
X
Search
Drug Profile

BIT 225

Alternative Names: BIT-225

Latest Information Update: 10 Aug 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Biotron
  • Class Antiretrovirals; Antivirals; Guanidines; Naphthalenes; Pyrazoles; Small molecules
  • Mechanism of Action Hepatitis C virus p7 protein inhibitors; Hepatitis C virus replication inhibitors; HIV replication inhibitors; Human immunodeficiency virus 1 vpu protein inhibitors; SARS coronavirus E protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II COVID 2019 infections; Hepatitis C; HIV infections; HIV-1 infections

Most Recent Events

  • 28 Jul 2023 Pharmacodynamics data from preclinical studies in COVID-2019 infections released by Biotron
  • 28 Jul 2023 Biotron completes the phase II trial for HIV-1 infections (Combination therapy, Treatment-naïve) in Thailand (PO) prior to July 2023 (ACTRN12621000937819)
  • 28 Jul 2023 Biotron completes the phase-II trial in HIV-1 infections (Treatment-experienced, Combination therapy) in Australia prior to July 2023 (ACTRN12621001354875)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top